Moreover, PDAC has high levels of expression of SF3B1, and recent studies have demonstrated a positive correlation between expression levels of wildtype (WT) SF3B1 and tumour malignancy[11,62], further supporting the search for drugs targeting this key spliceosomal factor. The gene discussed is SF3B1; the disease is neoplasm.